<DOC>
	<DOCNO>NCT02511834</DOCNO>
	<brief_summary>Post marketing surveillance ( PMS ) study . 200 patient enrol prospective , multi center , randomize , two-arm , open label , control , enrol patient multi vessel atherosclerotic coronary artery disease , schedule undergo Coronary artery bypass grafting ( CABG ) arterial graft IMA LAD , one saphenous vein graft ( SVG ) right territory one SVGs leave territory . Of vein graft , one select randomly receive treatment VEST another designate Control .</brief_summary>
	<brief_title>VEST III PMS Clinical Protocol</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Patient schedule onpump CABG clinical ground 2 . Two bypass vein graft bypass indicate follow : one ( 1 ) right coronary artery , 1 leave coronary artery IMA indicate LAD clinical ground 3 . Appropriately size accessible target coronary artery , minimum diameter 1.5 mm adequate vascular bed 4 . Ability give inform write consent 5 . Ability willingness comply study follow requirement 6 . Patient ≥ 18 ≤ 80 year age , Life expectancy ≥5 year 1 . Concomitant nonCABG cardiac procedure 2 . Prior cardiac surgery 3 . Emergency CABG surgery ( cardiogenic shock , inotropic pressure support , IABP ) 4 . Contraindication onpump CABG cardioplegic arrest ( e.g . severely calcified aorta ) 5 . Calcification intend anastomotic site , assess upon open chest , randomization 6 . Severe vein varicosity 7 . Prior debilitate stroke less 1 year surgery 8 . Severe renal dysfunction ( Cr &gt; 2.0 mg/dL &gt; 177 μmol/L ) 9 . Women child bear age 10 . Concomitant lifethreatening disease likely limit life expectancy le 5 year 11 . Indication Warfarin time surgery 12 . Inability tolerate comply require normal postoperative drug regimen ( antiplatelet , statin betablockers ) adequately control . 13. inability take aspirin 14 . Contraindication intravascular contrast material adequately control premedication 15 . Inability comply require followup include angiographic and/or CT image method . 16 . Participating investigational study either drug device influence collection valid data study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>